Distinct lung microbiota associate with HIV-associated chronic lung disease in children
Abstract Chronic lung disease (CLD) is a common co-morbidity for HIV-positive children and adolescents on antiretroviral therapy (ART) in sub-Saharan Africa. In this population, distinct airway microbiota may differentially confer risk of CLD. In a cross-sectional study of 202 HIV-infected children...
Main Authors: | Sudha Bhadriraju, Douglas W. Fadrosh, Meera K. Shenoy, Din L. Lin, Kole V. Lynch, Kathryn McCauley, Rashida A. Ferrand, Edith D. Majonga, Grace McHugh, Laurence Huang, Susan V. Lynch, John Z. Metcalfe |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2020-09-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-020-73085-1 |
Similar Items
-
The effect of azithromycin for management of HIV-associated chronic lung disease on right heart function: Results from the BREATHE trial
by: Edith D. Majonga, et al.
Published: (2021-12-01) -
Effect of antiretroviral therapy on longitudinal lung function trends in older children and adolescents with HIV-infection.
by: Sarah Rylance, et al.
Published: (2019-01-01) -
Moraxella-dominated pediatric nasopharyngeal microbiota associate with upper respiratory infection and sinusitis.
by: Kathryn E McCauley, et al.
Published: (2021-01-01) -
Gut microbiota in HIV–pneumonia patients is related to peripheral CD4 counts, lung microbiota, and in vitro macrophage dysfunction
by: Meera K. Shenoy, et al.
Published: (2019-03-01) -
Chronic lung disease in HIV-infected children established on antiretroviral therapy
by: Rylance, J, et al.
Published: (2016)